CRG L.P.

We are a premier healthcare investment firm that has managed over $3 billion of institutional capital since inception and its senior investment professionals have led over 50 investments. The firm seeks to commit between $20 to $300 million in each company and invests across the healthcare spectrum, including; medical devices, biopharmaceuticals, tools & diagnostics, services, and information technology. CRG provides growth capital in the form of long-term debt and equity to support innovative, commercial-stage healthcare companies that address large, unmet medical needs. The firm partners with public and private companies to provide flexible financing solutions and world-class support to achieve exceptional growth objectives with minimal dilution. We look for companies that are developing next-generation healthcare products, technologies, and services that address significant and substantial unmet medical needs. We have invested in companies representing large markets that target aging populations and obesity in developed economies; enterprises that address healthcare cost reduction; and, tools and diagnostic service companies that advance personalized medicine.